Pfm Health Sciences, LP I Teos Therapeutics, Inc. Transaction History

Pfm Health Sciences, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$17.77 - $21.6 $8.3 Million - $10.1 Million	-467,032 Reduced 86.82%	70,922 $1.39 Million
Q2 2022 Aug 15, 2022	BUY	$16.57 - $35.1 $8.91 Million - $18.9 Million	537,954 New	537,954 $11.1 Million
Q2 2021 Aug 16, 2021	SELL	$17.9 - $36.1 $4.16 Million - $8.38 Million	-232,216 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$30.86 - $44.2 $7.17 Million - $10.3 Million	232,216 New	232,216 $7.94 Million
Q4 2020 Feb 16, 2021	SELL	$21.59 - $33.95 $8.78 Million - $13.8 Million	-406,467 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.57 - $32.92 $7.14 Million - $13.4 Million	406,467 New	406,467 $10 Million

169

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $285M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.